US Broker Ratings

Clover Health Investments (CLOV) Stock Analysis: Unpacking the 63.76% Potential Upside

Clover Health Investments, Corp (NASDAQ: CLOV) has been a noteworthy player in the healthcare sector, specifically within the healthcare plans industry. Based in Wilmington, Delaware, Clover Health offers Medicare Advantage..

Arcellx, Inc. (ACLX) Stock Analysis: Navigating the Peaks and Valleys of Biotech Investing

Arcellx, Inc. (NASDAQ: ACLX) presents itself as a compelling yet challenging opportunity for investors in the biotechnology sector. With a market capitalization of $6.71 billion, Arcellx is a significant player..

Immunocore Holdings plc (IMCR)

⚠️ No article content returned.

..

Alvotech (ALVO) Stock Analysis: Exploring a 325% Upside Potential in the Biosimilar Market

Investors looking for opportunities in the healthcare sector might find Alvotech (NASDAQ: ALVO) an intriguing prospect. This Luxembourg-based company, with a market cap of $1.03 billion, is making significant strides..

BGM Group Ltd. (BGM) Stock Analysis: Examining the Healthcare Manufacturer’s Challenging Financial Landscape

BGM Group Ltd. (BGM), a healthcare sector player based in China, operates within the specialty and generic drug manufacturing industry. Despite its strategic positioning in the lucrative pharmaceutical market, BGM’s..

SS Innovations International (SSII): Navigating Growth in the Healthcare Sector with a 79.10% Revenue Surge

SS Innovations International, Inc. (SSII), a burgeoning entity in the healthcare sector, has garnered attention with its significant revenue growth of 79.10%. Though this Indian-based medical devices company operates on..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a Potential 53% Upside

Bausch Health Companies Inc. (NYSE: BHC), a key player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, is currently generating buzz among investors. With its..

Immunovant, Inc. (IMVT) Stock Analysis: A Promising 70.60% Upside Potential in Biotech

Investors are increasingly turning their attention to Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage biotechnology company focused on developing monoclonal antibodies for autoimmune diseases. With a market capitalization of $4.79 billion..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a Potential 62% Upside in the Healthcare Sector

Surgery Partners, Inc. (NASDAQ: SGRY), operating within the robust healthcare sector, specifically in the medical care facilities industry, presents an intriguing opportunity for investors seeking exposure to the burgeoning demand..

Zai Lab Limited (ZLAB) Stock Analysis: Exploring a 115.50% Potential Upside in the Biotech Sector

Zai Lab Limited (NASDAQ: ZLAB), a prominent player in the healthcare sector, offers investors a unique opportunity to delve into the rapidly evolving biotechnology industry. Headquartered in Pudong, China, this..

Schrodinger, Inc. (SDGR) Stock Analysis: A Look at 108.77% Potential Upside and Investor Ratings

Schrodinger, Inc. (NASDAQ: SDGR) operates at the cutting-edge intersection of technology and healthcare, leveraging its proprietary computational platform to revolutionize drug discovery and materials science. As investors evaluate the potential..

Crinetics Pharmaceuticals, Inc. (CRNX) Consensus: Uncovering a Potential 143.65% Upside in Biotech Innovation

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is at the forefront of innovation in the biotechnology sector, with a focus on developing novel therapeutics for rare endocrine diseases and endocrine-related tumors. The..

Harmony Biosciences Holdings (HRMY): Investor Outlook Reveals 56% Upside Potential

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) presents a compelling opportunity for investors intrigued by the biotechnology sector’s potential for high returns. With a market capitalization of $1.56 billion, this commercial-stage..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Exploring a 130.75% Upside Potential in the Biotechnology Sector

Beam Therapeutics Inc. (NASDAQ: BEAM) is capturing investor attention with its impressive potential upside of 130.75%, as indicated by the average analyst target price of $50.53. Based in Cambridge, Massachusetts,..

Alignment Healthcare, Inc. (ALHC) Investor Outlook: Exploring a 51% Upside Potential

Alignment Healthcare, Inc. (NASDAQ: ALHC) is capturing the attention of investors with its promising potential for growth. The company, operating in the healthcare plans industry, specializes in delivering a consumer-centric..

CONMED Corporation (CNMD) Stock Analysis: Is a 31.98% Upside Worth Your Investment?

CONMED Corporation (NASDAQ: CNMD), a notable player in the healthcare sector specializing in medical devices, currently presents an intriguing opportunity for investors. With its stock price now at $33.49, the..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Navigating Growth with a 15.70% Revenue Surge and a 3.86% Upside Potential

Investors eyeing the healthcare sector may find LeMaitre Vascular, Inc. (NASDAQ: LMAT) an intriguing prospect, especially considering its robust 15.70% revenue growth and the potential 3.86% upside based on current..

Addus HomeCare Corporation (ADUS) Stock Analysis: Unpacking a 47.77% Potential Upside in Healthcare

Investors seeking exposure in the healthcare sector may find Addus HomeCare Corporation (NASDAQ: ADUS) an intriguing proposition, especially given its nearly 48% potential upside according to analysts. With a market..

Galapagos NV (GLPG) Stock Analysis: Navigating a 13.28% Potential Upside in the Biotech Sector

Galapagos NV (NASDAQ: GLPG), a prominent player in the biotechnology arena, is captivating investor attention with its robust revenue growth and intriguing pipeline of innovative therapies. Despite the absence of..

Certara, Inc. (CERT) Stock Analysis: Exploring a Promising 60% Potential Upside

Certara, Inc. (NASDAQ: CERT) is capturing investor attention with its potential for significant upside, despite current market challenges. Specializing in healthcare information services, Certara provides cutting-edge biosimulation technology and software..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds